Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.40 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.38 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25965011 | 0.95 | GSK3A (0.44) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5535450 | 0.87 | GSK3A (0.47) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL17995365 | 0.87 | GSK3A (0.45) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL25599472 | 0.84 | GSK3A (0.43) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL29328204 | 0.83 | GSK3A (0.45) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5533650 | 0.77 | GSK3A (0.42) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5531699 | 0.74 | CA12 (0.50) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5575888 | 0.73 | NPBWR1 (0.43) | GSK3AGSK3BTRPV1PTGS2NR1H4 | |
| SCHEMBL17537378 | 0.73 | GSK3A (0.59) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5534241 | 0.69 | ADRB1 (0.38) | MPIPHOSPHO1NPBWR1CYP1A2MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230209990-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-29 | — | — | US | disclosed |
| US-20200220088-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200220088-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L3MBTL3, AGO2, ELAVL3 | GSK3A 3259/4885GSK3B 2484/4885TRPV1 1356/4885 |
| US-20230209990-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L3MBTL3, AGO2, ELAVL3 | GSK3A 3259/4885GSK3B 2484/4885TRPV1 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.